The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: risperdal consta     Quarter: 2016Q3

Total Records: 310     Number of Pages: 16

DRUGNAME PT EventCount
RISPERDAL CONSTA Muscle spasms 1
RISPERDAL CONSTA Nausea 1
RISPERDAL CONSTA Neoplasm malignant 1
RISPERDAL CONSTA Neuroleptic malignant syndrome 1
RISPERDAL CONSTA Ocular icterus 1
RISPERDAL CONSTA Overweight 1
RISPERDAL CONSTA Paraesthesia 1
RISPERDAL CONSTA Patella fracture 1
RISPERDAL CONSTA Patient uncooperative 1
RISPERDAL CONSTA Penile oedema 1
RISPERDAL CONSTA Persecutory delusion 1
RISPERDAL CONSTA Personality change 1
RISPERDAL CONSTA Pneumonia 1
RISPERDAL CONSTA Poor personal hygiene 1
RISPERDAL CONSTA Poor quality drug administered 1
RISPERDAL CONSTA Priapism 1
RISPERDAL CONSTA Product reconstitution issue 1
RISPERDAL CONSTA Product solubility abnormal 1
RISPERDAL CONSTA Prolactin-producing pituitary tumour 1
RISPERDAL CONSTA Psychomotor retardation 1

Total Records: 310     Number of Pages: 16